Cargando…

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence

Attention deficit hyperactivity disorder (ADHD) impacts significantly on the quality of life (QoL) of patients and their families. Choice of therapy is increasingly influenced by treatment satisfaction and patient preference, with once-daily modified-release methylphenidate (MPH-MR) formulations off...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rothenberger, Aribert, Becker, Andreas, Breuer, Dieter, Döpfner, Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Supplement
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180635/ https://www.ncbi.nlm.nih.gov/pubmed/21901416 http://dx.doi.org/10.1007/s00787-011-0203-3

Ejemplares similares

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011)

An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
por: Döpfner, Manfred, et al.
Publicado: (2011)

Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011)

Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
por: Breuer, Dieter, et al.
Publicado: (2011)

Relationship between quality of life and psychopathological profile: data from an observational study in children with ADHD
por: Becker, Andreas, et al.
Publicado: (2011)

What contributes to patient and parent satisfaction with medication in the treatment of children with ADHD? A report on the development of a new rating scale
por: Görtz-Dorten, Anja, et al.
Publicado: (2011)

An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate
por: Hautmann, Christopher, et al.
Publicado: (2013)

Influence of methylphenidate on brain development – an update of recent animal experiments
por: Grund, Thorsten, et al.
Publicado: (2006)

Editorial: Neurofeedback in ADHD
por: Arns, Martijn, et al.
Publicado: (2015)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008)

Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009)

Serum level of semicarbazide-sensitive amine oxidase in children with ADHD
por: Roessner, Veit, et al.
Publicado: (2006)

Predicting delinquent behavior in young adults with a childhood diagnosis of ADHD: results from the Cologne Adaptive Multimodal Treatment (CAMT) Study
por: Breuer, Dieter, et al.
Publicado: (2020)

Guideline adherence in German routine care of children and adolescents with ADHD: an observational study
por: Mücke, Kristina, et al.
Publicado: (2020)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD?
por: Roessner, Veit, et al.
Publicado: (2007)

Questioning the long-term stability of the additive model in comorbid CTD+ADHD - The transition from childhood to adulthood
por: Müller, Olga, et al.
Publicado: (2018)

Effectiveness and safety of a long-acting, once-daily, two-phase release formulation of methylphenidate (Ritalin(®) LA) in school children under daily practice conditions
por: Haertling, Fabian, et al.
Publicado: (2014)

Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD
por: Cataldo, Marc, et al.
Publicado: (2022)

Pathophysiology of ADHD and associated problems—starting points for NF interventions?
por: Albrecht, Björn, et al.
Publicado: (2015)

Yes, I can - maybe … Effects of placebo-related instructions on neuroregulation in children with ADHD
por: Gevensleben, Holger, et al.
Publicado: (2020)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Recommendations for a better patient care in daily clinical practice: a joint perspective of ESCAP and ECAP
por: Rothenberger, Aribert, et al.
Publicado: (2012)

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
por: Doesch, Andreas O, et al.
Publicado: (2013)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018)

Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial
por: Gevensleben, Holger, et al.
Publicado: (2010)

Cognitive Control Over Visual Motion Processing – Are Children With ADHD Especially Compromised? A Pilot Study of Flanker Task Event-Related Potentials
por: Lange-Malecki, Bettina, et al.
Publicado: (2018)

Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications
por: Heile, Michael, et al.
Publicado: (2018)

Electrophysiological evidence for abnormal preparatory states and inhibitory processing in adult ADHD
por: McLoughlin, Gráinne, et al.
Publicado: (2010)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

Changes and Challenges: Managing ADHD in a Fast-Paced World
por: Manos, Michael J., et al.
Publicado: (2007)

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)

Cognitive-electrophysiological indices of attentional and inhibitory processing in adults with ADHD: familial effects
por: McLoughlin, Gráinne, et al.
Publicado: (2011)

Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Parent–child inpatient treatment for children with behavioural and emotional disorders: a multilevel analysis of within-subjects effects
por: Ise, Elena, et al.
Publicado: (2015)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_fssph2b1d31h21k48u69ukkmfr